The Evidence for Cognitive Behavioral Therapy

The Evidence for Cognitive Behavioral Therapy Letters 1. Parasrampuria DA, Mendell J, Shi M, Matsushima N, Zahir H, Truitt K. frailty, may still exist. Some covariates (eg, categories of Edoxaban drug-drug interactions with ketoconazole, erythromycin, and liver diseases) can act as a proxy for laboratory tests. Frailty cyclosporine. Br J Clin Pharmacol. 2016;82(6):1591-1600. is difficult to measure and quantify clinically. Self-controlled 2. Heidbuchel H, Verhamme P, Alings M, et al. Updated European Heart design, as advised by Li and colleagues, may be needed to Rhythm Association practical guide on the use of non–vitamin-K antagonist ascertain its influence. Specific drug characteristics, for anticoagulants in patients with non-valvular atrial fibrillation. Eur Heart J.2017; 38(27):2137-2149. example thrombocytopenia associated with rifampin, may 3. Romley JA, Gong C, Jena AB, Goldman DP, Williams B, Peters A. Association change bleeding risk beyond the influence of altered NOAC between use of warfarin with common sulfonylureas and serious hypoglycemic levels. Drug-disease interactions also make the risk estima- events. BMJ. 2015;351:h6223. tion of adverse drug reactions more difficult. Wang and col- 4. Grosset J, Leventis S. Adverse effects of rifampin. Rev Infect Dis. 1983; leagues comment that the increased risk associated with 5(suppl 3):S440-S450. phenytoin may be a bystander of intracranial hemorrhage 5. Dumbreck http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

The Evidence for Cognitive Behavioral Therapy

JAMA , Volume 319 (8) – Feb 27, 2018
Preview Only
3 pages

Loading next page...
 
/lp/jama/the-evidence-for-cognitive-behavioral-therapy-nQGQpomE6d
Publisher
American Medical Association
Copyright
Copyright 2018 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
D.O.I.
10.1001/jama.2017.20826
Publisher site
See Article on Publisher Site

Abstract

Letters 1. Parasrampuria DA, Mendell J, Shi M, Matsushima N, Zahir H, Truitt K. frailty, may still exist. Some covariates (eg, categories of Edoxaban drug-drug interactions with ketoconazole, erythromycin, and liver diseases) can act as a proxy for laboratory tests. Frailty cyclosporine. Br J Clin Pharmacol. 2016;82(6):1591-1600. is difficult to measure and quantify clinically. Self-controlled 2. Heidbuchel H, Verhamme P, Alings M, et al. Updated European Heart design, as advised by Li and colleagues, may be needed to Rhythm Association practical guide on the use of non–vitamin-K antagonist ascertain its influence. Specific drug characteristics, for anticoagulants in patients with non-valvular atrial fibrillation. Eur Heart J.2017; 38(27):2137-2149. example thrombocytopenia associated with rifampin, may 3. Romley JA, Gong C, Jena AB, Goldman DP, Williams B, Peters A. Association change bleeding risk beyond the influence of altered NOAC between use of warfarin with common sulfonylureas and serious hypoglycemic levels. Drug-disease interactions also make the risk estima- events. BMJ. 2015;351:h6223. tion of adverse drug reactions more difficult. Wang and col- 4. Grosset J, Leventis S. Adverse effects of rifampin. Rev Infect Dis. 1983; leagues comment that the increased risk associated with 5(suppl 3):S440-S450. phenytoin may be a bystander of intracranial hemorrhage 5. Dumbreck

Journal

JAMAAmerican Medical Association

Published: Feb 27, 2018

References

Sorry, we don’t have permission to share this article on DeepDyve,
but here are related articles that you can start reading right now:

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off